Centessa Pharmaceuticals plc (CNTA) Misses Q2 EPS by 5c
Tweet
Share
E-mail
Get Alerts CNTA Hot Sheet
Join SI Premium – FREE
Centessa Pharmaceuticals plc (NASDAQ: CNTA) reported Q2 EPS of ($0.38), $0.05 worse than the analyst estimate of ($0.33).
For earnings history and earnings-related data on Centessa Pharmaceuticals plc (CNTA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
- Sensient Technologies secures $400M term loan facility with CoBank
- Morgan Stanley Private Credit Fund Caps Redemptions At 5%
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
